IP Library Patent Application 17787187
Patent Application
App. No. 17/787,187

TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATING ONYCHOMYCOSIS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/787,187
Abstract

The present invention relates to topical pharmaceutical compositions for treatment or prophylaxis of onychomycosis, and other fungal conditions caused by Trichophyton rubrum and/or Trichophyton mentagrophytes, comprising an effective amount of an amine-based anti-fungal compound, such as terbinafine or a pharmaceutically acceptable salt thereof, and monocaprin, in certain proportions.

Claims (18)

1 . A topical pharmaceutical composition for the treatment or prophylaxis of onychomycosis, or other fungal conditions of the nail unit caused by Trichophyton rubrum and/or Trichophyton mentagrophytes, in a patient in need thereof, said composition comprising a therapeutically effective amount of an amine-based anti-fungal agent or pharmaceutically acceptable salt thereof, and monocaprin, in a wt.% ratio of 5:1 to 1:6 (amine free base: monocaprin), in a topically administrable vehicle.

2 . A composition according to claim 1 wherein the amine-based anti-fungal agent is selected from allylamines and the pharmaceutically acceptable salts thereof.

3 . A composition according to claim 2 wherein the amine-based anti-fungal agent is selected from terbinafine and the pharmaceutically acceptable salts thereof.

4 . A composition according to claim 3 wherein the terbinafine and monocaprin are present in a wt.% ratio of 3.5:1 to 1:1.4 (amine free base: monocaprin) (based on the total weight of the composition).

5 . A composition according to claim 3 wherein the terbinafine and monocaprin are present in a wt.% ratio of 1:1.4 to 1:5.7 (amine free base: monocaprin).

6 . A composition according to claim 1 comprising 1 wt.% terbinafine (free base).

7 . A composition according to claim 1 comprising 1 wt.% terbinafine (free base) and between 1.4 and 5.7 wt.% monocaprin.

8 . A composition according to claim 1 wherein the topically administrable vehicle comprises at least one volatile solvent selected from the group consisting of ethanol, propyl alcohol, isopropyl alcohol, n-butyl alcohol, t-butyl alcohol, butoxy ethanol, acetone, ethyl acetate and butyl acetate, and mixtures thereof.

9 . A composition according to claim 8 wherein the at least one volatile solvent comprises ethanol.

10 . A composition according to claim 8 which further comprises one or more excipients selected from the group consisting of pH adjusting agents, humectants, film extenders, chelating agents, antioxidants, preservatives, plasticizers, penetration enhancers, fragrance, colorants, surfactants, emollients, gelling agents, and radical scavengers.

11 . A composition according to claim 10 which comprises an emollient selected from C 12 -C 15 alcohol lactates and cetyl alcohol.

12 . A composition according to claim 1 which comprises a second pharmaceutically active agent.

13 . A composition according to claim 12 wherein the second pharmaceutically active agent is selected from the group consisting of an antibacterial agent, anti-fungal agent, corticosteroid and vitamin D analogue.

14 . A composition according to claim 1 , wherein the fungal condition is selected from the group consisting of tinea pedis, tinea cruis, dermatophysis and onychomycosis.

15 . A composition according to claim 1 comprising: Terbinafine, 1 wt% Monocaprin 1.4 wt.% or 5.7 wt.% ethyl alcohol butylhydroxytoluene (BHT) stearyl alcohol cetyl alcohol polysorbate 60 propylene glycol .

16 . A method for the topical treatment or prophylaxis of onychomycosis, or other fungal conditions of the nail unit caused by Trichophyton rubrum and/or Trichophyton mentagrophytes, in a patient in need thereof, comprising topically applying to the affected area a composition according to claim 1 .

17 . A method according to claim 16 wherein the fungal condition is selected from the group consisting of tinea pedis, tinea cruis, and dermatophysis.

18 . A method according to claim 16 , wherein the fungal condition is onychomycosis.

Assignments (2)
CHANGE OF NAME Recorded Jan 18, 2024
From: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: HALEON US HOLDINGS LLC
Reel/Frame 066344/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2023
From: BULSARA, PALLAV ARVIND; MOORE, DAVID JOHN; SHALVIRI, ALIREZA
To: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Reel/Frame 065504/0725 →